Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort

QR Code

Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort

Aims: To describe aspirin use in primary and secondary prevention and to determine the incremental costs-effectiveness ratio (ICER) per life year gain (LYG) of aspirin use among subjects with, or at high risk of atherothrombotic disease. Design and Subjects: To project the cost-effectiveness of aspi...

Full description

Bibliographic Details
Main Authors:	Ademi, Z., Liew, D., Hollingsworth, B., Steg, P., Bhatt, D., Reid, Christopher
Format:	Journal Article
Published:	2013
Online Access:	http://hdl.handle.net/20.500.11937/24164

Similar Items

Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry
by: Ademi, Z., et al.
Published: (2011)

The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-Year follow-up data from the australian REACH registry
by: Ademi, Z., et al.
Published: (2013)

Outcomes from the REACH registry for Australian general practice patients with or at high risk of atherothrombosis
by: Reid, Christopher, et al.
Published: (2012)

Australians at Risk: Management of Cardiovascular Risk Factors in the REACH Registry
by: Reid, Christopher, et al.
Published: (2008)

Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry
by: Abtan, J., et al.
Published: (2017)

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)

Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study
by: Si, Si, et al.
Published: (2018)

Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013)

ASPREE-D: Aspirin for the prevention of depression in the elderly
by: Berk, M., et al.
Published: (2016)

Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
by: Ademi, Z., et al.
Published: (2014)

Economic implications of obesity among people with atherothrombotic disease
by: Ademi, Z., et al.
Published: (2010)

Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk
by: Halkes, P.H.A., et al.
Published: (2008)

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)

Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019)

The Role of Clinical Registries in Monitoring Drug Safety and Efficacy
by: Reid, Christopher
Published: (2015)

Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial
by: Berk, M., et al.
Published: (2020)

Characteristics of national and major regional percutaneous coronary intervention registries: A structured literature review
by: Biswas, S., et al.
Published: (2018)

Aspirin for the prevention of cognitive decline in the elderly: Rationale and design of a neuro-vascular imaging study (ENVIS-ion)
by: Reid, Christopher, et al.
Published: (2012)

Overview of pharmacoeconomic modelling methods
by: Ademi, Z., et al.
Published: (2013)

Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)

Twisted Aspirin Crystals
by: Cui, X., et al.
Published: (2013)

The aspirin in reducing events in the elderly trial: Statistical analysis plan
by: Wolfe, R., et al.
Published: (2018)

Bmi and gender as mediators in the association between ethnicity and glycemic control in primary healthcare settings: Malaysia national diabetes registry cohort / Eliana Ahmad
by: Eliana, Ahmad
Published: (2019)

Simple Synthetic Receptors for Aspirin
by: Nguyen, Thanh Vinh, et al.
Published: (2014)

Effect of aspirin on all-cause mortality in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Hidden dangers of antibiotic use: increased gut permeability mediated by increased pancreatic proteases reaching the colon
by: Spiller, Robin C.
Published: (2018)

Funding linked to ongoing research: Impact of the bosentan patient registry on pricing in Australia
by: Wlodarczyk, J., et al.
Published: (2011)

Quality Control Activities Associated with Registries in Interventional Cardiology and Surgery
by: Andrianopoulos, N., et al.
Published: (2011)

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
by: Sprigg, Nikola, et al.
Published: (2008)

Implementing Sustainable Data Collection for a Cardiac Outcomes Registry in an Australian Public Hospital
by: Cox, N., et al.
Published: (2017)

Effect of aspirin on disability-free survival in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Randomized factorial trial of esomeprazole and aspirin in Barrett’s oesophagus: the Aspirin and Esomeprazole Chemoprevention in Barrett’s metaplasia Trial (AspECT)
by: Jankowski, Janusz A.Z., et al.
Published: (2018)

Effect of aspirin on cancer incidence and mortality in older adults.
by: McNeil, John J, et al.
Published: (2020)

Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-Analysis of randomised clinical trials
by: Selak, V., et al.
Published: (2019)

A PRACTICAL DEFINITION OF LATE STENT THROMBOSIS: INSIGHTS FROM THE MELBOURNE INTERVENTIONAL GROUP REGISTRY
by: Yan, B., et al.
Published: (2011)

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
by: Ryan, Joanne, et al.
Published: (2020)

Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry
by: Eccleston, D., et al.
Published: (2016)

Pahang melioidosis registry
by: How, Soon Hin, et al.
Published: (2009)

Pahang meliodosis registry
by: How, Soon Hin, et al.
Published: (2007)

Cannot write session to /tmp/vufind_sessions/sess_nu839bur23926iia3hdfkc9v2b